Activity Title: The Intersection Between COPD & Cardiometabolic Conditions
Activity Format: Infographic Activity
Program Description:
Chronic obstructive pulmonary disease (COPD) is a chronic, complex illness with multiple systemic effects, including cardiometabolic conditions, and requires an integrated approach for its optimal management. Not only do these conditions affect patient adherence by adding to the burden of polypharmacy, they have been shown to independently impact patient response to COPD therapy.
This activity will consist of high-impact visual experience using interactive infographics and will discuss the prevalence and identification of cardiometabolic conditions in patients with COPD, the most recent advances in COPD research, and offer evidence-based management strategies based on the GOLD 2018 recommendations. The activity will also include patient case examples and provide expert recommendations for collaborative team effort and patient self-management for combatting the cardiometabolic conditions commonly associated with COPD and their impact on COPD management and outcomes.
Estimated Time to Complete: 1.0 hours
Release Date: July 31, 2018
Expiration Date: July 31, 2019
Credit Type(s) Available: ACCME, ANCC
Maximum Credits: 1.0
Provided By:
CME: This activity is jointly provided by The University of Cincinnati and Tarsus Cardio Inc. dba Cardiometabolic Health Congress
CE: This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress
Commercial Supporter
Multi-supported by educational grants from AstraZeneca and Sunovion Pharmaceuticals Inc.
Intended Audience:
US-based healthcare professionals, including pulmonologists, cardiologists, primary care physicians, nurse practitioners, nurses, and physician assistants.
Educational Objectives:
Upon completion of this activity, participants should be able to:
- Discuss the cardiometabolic conditions commonly associated with COPD and their impact on COPD management and outcomes
- Apply GOLD 2018 guideline assessment and management strategies, incorporating the latest clinical evidence to guide development of individualized management plans
- Identify a collaborative team approach to manage COPD and common cardiometabolic conditions and reduce barriers to patient self-management
Faculty Information:
Robert D. Brook, MD
- Professor of Cardiovascular Medicine
- Director, Comprehensive Hypertension Center
- Preventive Cardiology and Lipid Management Program
- University of Michigan
- Ann Arbor, MI
Disclosures:
Steering Committee: GSK
Alanna Kendig, FNP-BC, MSN, CCRN
- Pulmonary & Critical Care Nurse Practitioner
- Weill Cornell Medical Center
- New York, NY
Disclosures: Ms. Kendig has nothing to disclose.
Jill A. Ohar, MD
- Professor of Medicine
- Wake Forest University School of Medicine
- Director of Respiratory Care, Pulmonary
- Rehabilitation and the Pulmonary Function Laboratory
- Wake Forest University Medical Center
- Winston Salem, NC
Disclosures:
Consultant: Astra Zeneca, Theravance
Research Support and Consultant: Sunovion
Disclosure of Conflicts of Interest:
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Accreditor Disclosures:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Karin McAdams has nothing to disclose.
Bruce Gebhardt, MD has nothing to disclose.
Susan P. Tyler, M.Ed., CMP, CHCP, FACEHP has nothing to disclose.
Accreditation
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and CMHC.
The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement(s):
Physician Credit Designation
The University of Cincinnati designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
There are 0.1 pharmacotherapy hours available for this activity.
University of Cincinnati Contact Information:
For information about the accreditation of this program, please contact UC at 513-558-7277 or uc-cloudcme@ucmail.uc.edu
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions for CME/CE Credit:
This activity is offered at no cost to participants. During the period July 31, 2018 through July 31, 2019, participants must follow these steps in order to receive CME/CE credit:
- Sign In or Register at https://www.cardiometabolichealth.org/my-account.html
- Read and accept the Terms & Conditions including the learning objectives and faculty disclosures.
- Complete the pre-test by recording the best answer to each question in the answer key. There is no scoring of the pre-test questions section.
- Review the educational activity.
- Complete the post-test by recording the best answer to each question in the answer key. Successful completion of the post-test is required to earn CME/CE credit. Successful completion is defined as a cumulative score of at least 70%.
- Complete the online evaluation form.
- After successfully completing the post-test and online evaluation form, your CME/CE certificate will be generated and will be available immediately for print.
For information about the nursing accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.
If you have any other questions relating to your certificate or other issues with the activity, please contact info@cardiometabolichealth.org
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
